<DOC>
	<DOC>NCT00858325</DOC>
	<brief_summary>The primary objective of this study is to characterise the pharmacokinetics and dose proportionality of daptomycin after single and multiple (once daily) 4mg/kg and 6 mg/kg doses of daptomycin in healthy Chinese volunteers.</brief_summary>
	<brief_title>Pharmacokinetic Study of Daptomycin in Healthy Chinese Subjects Living in China</brief_title>
	<detailed_description />
	<mesh_term>Daptomycin</mesh_term>
	<criteria>Men or women (not of childbearing potential) of Chinese ethnicity Weight between 55Kg to 90Kg and have a Body Mass Index (BMI) between 18 and 25 kg/m2 Have a calculated creatinine clearance within range from 80 to 120 ml/min inclusive Unable to discontinue use of HMGCoA reductase inhibitor therapy within 7 days prior to first dose of study drug through discharge from unit CPK &gt; 2X ULN (upper limit of normal)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>Cubicin</keyword>
	<keyword>PK</keyword>
	<keyword>China Registration</keyword>
	<keyword>Pharmacokinetics</keyword>
</DOC>